These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7662572)

  • 41. Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index.
    Dong Z; Huang J; Huang L; Chen X; Yin Q; Yang D
    J Dermatol; 2013 Mar; 40(3):188-92. PubMed ID: 23289590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
    Legro RS; Finegood D; Dunaif A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index.
    Vuguin P; Sopher AB; Roumimper H; Chin V; Silfen M; McMahon DJ; Fennoy I; Oberfield SE
    Horm Res Paediatr; 2017; 87(6):359-367. PubMed ID: 28478437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
    Li L; Feng Q; Ye M; He Y; Yao A; Shi K
    J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome.
    Mendonça HC; Montenegro RM; Foss MC; Silva de Sá MF; Ferriani RA
    Braz J Med Biol Res; 2004 May; 37(5):729-36. PubMed ID: 15107936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
    Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
    Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
    Gennarelli G; Holte J; Wide L; Berne C; Lithell H
    Hum Reprod; 1998 Mar; 13(3):535-41. PubMed ID: 9572406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
    Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
    Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
    Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF
    J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycystic ovary syndrome and abnormalities in glucose tolerance.
    Bhattacharya SM
    Int J Gynaecol Obstet; 2009 Apr; 105(1):29-31. PubMed ID: 19155002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
    Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.
    Ciampelli M; Fulghesu AM; Cucinelli F; Pavone V; Caruso A; Mancuso S; Lanzone A
    Hum Reprod; 1997 Sep; 12(9):1897-901. PubMed ID: 9363702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.